Study of efficacy and safety of reduced chemotherapy and risk evaluation of perforation by Endoscopy for gastrointestinal non-Hodgkin Lymphoma
Phase 2
Recruiting
- Conditions
- Gastrointestinal non-Hodgkin lymphoma
- Registration Number
- JPRN-UMIN000026100
- Lead Sponsor
- Gifu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) CNS involvement 2) Serologically positive for HIVAb 3) Perforation or penetration of the digestive tract before treatment 4) Severe infection or clinical complication 5) Pregnant, possible pregnant, or breastfeeding woman 6) Active malignancy concomitantly existed 7) Known allergy for study drugs 8) Known resistance for study drugs 9) Patients who have been judged by the investigator to be inappropriate for participation in this clinical trial for other reasons.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method